Antipsychotic Initiation Ups Risk for Head Injury, TBI in Alzheimer Disease
TBI injury risk up for quetiapine vs risperidone users.
Alzheimer Disease and Dementia
Review Identifies Current Diagnostic Methods, Pharmacologic, Nonpharmacologic Approaches to Dementia
Medical history, cognitive and physical examination, laboratory testing, and brain imaging can help identify causes of dementia, and several pharmacologic and nonpharmacologic approaches can help manage the disease.
More Hospital Days Seen With Antipsychotic Use in Alzheimer Disease
Number of hospital days up by more than 50% in AD patients initiating antipsychotic medication.
New Alzheimer Disease Drug to Be Submitted for FDA Approval
New analysis of study results suggests highest dose of aducanumab may help slow cognitive decline.
Neurologic Impairment May Persist in HIV Encephalopathy Despite Potent ART
Despite potent antiretroviral therapy, HIV-associated dementia results in significant morbidity and mortality.
Exercise May Slow Brain Deterioration in Alzheimer Disease
Findings did not differ between aerobic exercise and stretching and toning.
Screening for Cognitive Decline in Primary Care
Although an estimated 82 million people worldwide will be affected by dementia by 2030, research demonstrates that cognitive decline often goes unrecognized in primary care settings.
Migraines Linked to Higher Risk for Dementia, Alzheimer Disease
However, no link seen between migraines and vascular dementia.
Essential Steps to Implementing Guidelines for Cognitive Dysfunction in Diabetes
Evidence to date suggests that the risk for all-cause dementia is 40% to 60% higher in patients with type 1 or type 2 diabetes.
Physical Activity and Low Vascular Risk Protective Against Cognitive Decline in AD
Engaging in regular physical activity and taking active measures to reduce vascular risk may have a synergistic effect in delaying the progression of Alzheimer disease.
Next post in Neurology Information Center
